Target intelligence / Profile preview

UBX domain-containing protein 1 (UBXN1)

Target
UBXN1
Molecular classification
Other (Ubiquitin-binding protein; Ubiquitin pathway regulator), Ubiquitin pathway protein (contains UBX and UBA domains)
01

Overview

UBXN1 is a member of the UBX domain-containing protein family, characterized by the presence of a UBX domain at its C-terminus and a UBA (ubiquitin-associated) domain at the N-terminus[2][6]. UBXN1 acts as a cellular receptor for K6-linked polyubiquitin chains, particularly those attached to autoubiquitinated BRCA1, and through bipartite interactions both with ubiquitin and with protein substrates, UBXN1 serves as an inhibitor of BRCA1/BARD1 E3 ligase activity[1][3]. It is also recruited upon viral infection to regulate the RIG-I-like receptor and NF-kappa-B pathways, thus modulating the innate immune response[3][5]. UBXN1 is involved in the coupling of ER-associated protein deglycosylation to proteasome-mediated degradation, supporting protein quality control mechanisms in the cell[3]. There is no evidence that UBXN1 is conjugated in a ubiquitin-like fashion, despite its structural resemblance to ubiquitin; rather, it serves as a regulator and receptor for ubiquitin-mediated signaling[2][6]. Defects in ubiquitin pathway proteins are associated with diverse diseases, including cancer and inflammatory disorders, although UBXN1 itself is not currently a direct therapeutic target[1][3][5].

Other names
UBXN1SAKS1LOC510352B28UBXD10SAPK substrate protein 1UBA/UBX 33.3 kDa protein
02

Biological functions

Regulation of E3 ubiquitin ligase activity (inhibits BRCA1/BARD1 complex)Modulation of innate immune responses (inhibits RIG-I-like receptor and NF-kappa-B pathways)Coupling deglycosylation and proteasome-mediated degradation of misfolded proteinsUbiquitin binding and participation in protein quality control
03

Disease associations

Cancer (regulation of BRCA1, a tumor suppressor)Inflammation (regulates NF-kappa-B and immune signaling)Other: protein misfolding disorders, innate immune dysregulation

Beyond the preview

Go deeper on UBX domain-containing protein 1 (UBXN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UBX domain-containing protein 1 (UBXN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call